Immunotherapy has improved first-line therapy for small cell lung cancer and has activity in the relapsed setting as well. The immunobiology of small cell lung cancer poses challenges for immunotherapy, and efforts are underway to unlock to the potential of immunotherapy through the identification of meaningful disease subsets and the development of novel combination therapies.Lung cancer is a leading cause of cancer-related mortality despite continued advances in diagnostic and therapeutic strategies. Although the development of immune checkpoint inhibitors has revolutionized the treatment landscape for advanced non-small cell lung cancer, many patients either have primary resistance to these agents or eventually develop secondary resistance necessitating a change to an alternate therapy. Understanding novel patterns of response to immunotherapy is crucial in determining appropriate selection and sequencing of treatment. Chemotherapy remains the standard of care in immunotherapy-refractory disease, but multiple trials are ongoing to explore the role of combination radioimmunotherapy and rechallenging with immunotherapy either alone or in combination with other antineoplastic agents.The initial treatment regimens for advanced non-small cell lung cancer (NSCLC) have drastically evolved over the last 15 years with the rapid development of improved genomic sequencing technologies and the emergence of immune checkpoint inhibitors. https://www.selleckchem.com/products/l-arginine-l-glutamate.html Highly active oral kinase inhibitors are now approved for several molecularly defined subsets of NSCLC, including those harboring alterations in the EGFR, ALK, ROS1, BRAF, MET, RET, and NTRK genes, although acquired resistance to these targeted therapies remains a significant clinical challenge. In lung cancers lacking targetable mutations, programmed death 1/programmed death ligand 1 immune checkpoint inhibitors, used alone or in combination with cytotoxic T-lymphocyte-associated protein 4 inhibitors and/or cytotoxic chemotherapy, have led to meaningful improvements in overall survival. With many therapeutic options available to patients, here we review the recommended frontline treatment regimens for advanced NSCLC with and without targetable genomic drivers.Anti-PD-(L)1 therapy represents a turning point in lung cancer immunotherapy, moving from previously ineffective enhancer strategies to immune checkpoints as standard first- and second-line therapies. This unprecedented success highlights the importance of mechanisms to escape immune attack, such PD-1/PD-L1 axis, and emphasize the importance to better understand the tumor immune microenvironment. Analyzing the specifics of immune response against lung tumor cells and how malignant cells progressively adapt to this pressure may help to understand which are the key aspects to guide the development of new therapeutic strategies. Here we review the past and present of clinical lung cancer immunotherapy and give a perspective for the future development based on emerging biological insights.Seymour fractures of the toe are physeal fractures with often occult concomitant nail bed injuries and thus are open fractures. They are uncommon injuries that without proper treatment can result in osteomyelitis. The literature has sparse information regarding the clinical outcomes for these injuries.
A single-center retrospective review included juxta-epiphyseal fractures or Salter-Harris I/II fracture of the toe with documented concomitant nail bed injury or laceration. Clinical and radiographic data were recorded for consecutive fractures. The primary outcome was the incidence of osteomyelitis. Secondary outcomes included premature physeal arrest, development of nail dystrophy, and functionality of the toe.
Between 2006 and 2019, 19 patients were treated for this injury by the pediatric orthopaedic division. Complications included osteomyelitis (n=6), physeal arrest (n=4), and nail dystrophy (n=1). Days from injury to definitive treatment were significantly greater in patients who developed osteomyelitis compared with those who did not (P&lt;0.01). Patients were significantly more likely to develop osteomyelitis if they did not receive acute definitive treatment (&lt;48?h) (P&lt;0.001; likelihood ratio, 17.9).
Prompt definitive treatment of Seymour fractures of the toe was associated with a lower incidence of osteomyelitis. Greater awareness for these seemingly innocuous injuries is needed to provide an early treatment that may reduce the rate of osteomyelitis.
Level IV-case series.
Level IV-case series.Weldon, A, Duncan, MJ, Turner, A, LaPlaca, D, Sampaio, J, and Christie, CJ. Practices of strength and conditioning coaches a snapshot from different sports, countries, and expertise levels. J Strength Cond Res XX(X) 000-000, 2020-This study describes the practices of strength and conditioning coaches (SCCs) from different sports, countries, and expertise levels. One hundred fifty-six SCCs (31.9 ± 8.9 years old) completed an online survey, consisting of 40 questions (36 fixed response and 4 open-ended), with 8 sections as follows (a) background information, (b) muscular strength and power development, (c) speed development, (d) plyometrics, (e) flexibility development, (f) physical testing, (g) technology use, and (h) programming and any additional comments. Responses were received from 48 sports and 17 countries. This study provides exploratory evidence incorporating responses primarily in soccer (45%), track and field (30%), volleyball (23%), golf (17%), and tennis (17%). A bachelor's degree or higher were held by 99% of SCCs, of which 94% were in a sports science-related field, and 71% held a strength and conditioning related certification or accreditation. Periodization strategies and physical testing were used by 96% and 94% of SCCs respectively. The hang clean (82%), power clean (76%), and clean high pull (63%) were the most prescribed Olympic weightlifting exercises. Multiple hops/lunges (84%) were the most prescribed plyometrics exercises. For open-ended questions, 40% of SCCs wanted to integrate more technology into their programs and 30% believed technology will be the main future trend. Strength and conditioning coaches from different sports, countries, and expertise levels can use the information presented in this study to review their current practices and provide a source of new ideas for diversifying or modifying future practices.